| View |
|
DRP-10967
|
Doxorubicin Hydrochloride
|
Doxonorm-50
|
50 mg
|
Lyophilized Powder For Injection
|
-
|
Admac Lifesciences
|
India
|
-
|
12 January 2022
|
12 January 2027
|
| View |
|
DRP-10989
|
Doxorubicin Hydrochloride
|
Doxonorm-10
|
10 mg
|
Lyophilized Powder For Injetcion for I.V. Infusion
|
-
|
Admac Lifesciences
|
India
|
-
|
29 December 2021
|
29 December 2026
|
| View |
|
DR-XY47619
|
Desloratadine
|
Destavell
|
5 mg
|
Film Coated Tablets
|
-
|
PT. Novell Pharmaceutical Laboratories
|
Indonesia
|
-
|
23 February 2022
|
21 December 2026
|
| View |
|
DRP-10904
|
Co-Amoxiclav
|
Comxicla
|
1g
|
Film Coated Tablet
|
-
|
Indchemie Health Specialties Private Limited
|
India
|
-
|
17 December 2021
|
17 December 2026
|
| View |
|
DRP-10872
|
Cefotaxime Sodium + Sulbactam Sodium
|
Tricetam
|
1g/500mg
|
Powder For Injection (IM/IV)
|
-
|
Theon Pharmaceuticals Limited
|
India
|
-
|
28 December 2021
|
28 December 2026
|
| View |
|
DRP-10962
|
Etoricoxib
|
Etorinov - 120
|
120 mg
|
Film-Coated Tablet
|
Non-steroidal Anti-inflammatory Drug
COX-2 Inhibitor)
|
ACME Formulation Pvt. Ltd.
|
India
|
Initial
|
23 December 2021
|
23 December 2026
|
| View |
|
DRP-10963
|
Etoricoxib
|
Etorinov - 90
|
90 mg
|
Film-Coated Tablet
|
-
|
ACME Formulation Pvt. Ltd.
|
India
|
-
|
23 December 2021
|
23 December 2026
|
| View |
|
HMRP-37
|
Vitex Negundo L. (Lagundi Leaf)
|
Ofplemed
|
300 mg/5mL
|
Syrup (Banana Flavor)
|
-
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
-
|
20 December 2021
|
20 December 2026
|
| View |
|
HMRP-36
|
Vitex Negundo L. (Lagundi) Leaf
|
Ofplemed
|
300 mg/5 mL
|
Syrup (Banana Flavor)
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
-
|
20 December 2021
|
20 December 2026
|
| View |
|
HMRP-35
|
Vitex Negundo L. (Lagundi) Leaf
|
Ofplemed
|
300 mg/5 mL
|
Syrup (Strawberry Flavor)
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
-
|
20 December 2021
|
20 December 2026
|
| View |
|
HMRP-34
|
Vitex Negundo L. (Lagundi) Leaf
|
Ofplemed
|
300 mg/5 mL
|
Syrup (Strawberry Flavor)
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
-
|
20 December 2021
|
20 December 2026
|
| View |
|
HMRP-33
|
Vitex Negundo L. (Lagundi) Leaf
|
Ofplemed
|
300 mg/5 mL
|
Syrup (Ponkan Flavor)
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
-
|
20 December 2021
|
20 December 2026
|
| View |
|
HMRP-32
|
Vitex Negundo L. (Lagundi) Leaf
|
Ofplemed
|
300 mg/5 mL
|
Syrup (Ponkan Flavor)
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
-
|
20 December 2021
|
20 December 2026
|
| View |
|
DRP-11010
|
Bupivacaine hydrochloride in Dextrose
|
Bupinova
|
5 mg/80 mg per mL
|
Solution for Injection
(Intrathecal)
|
Local Anesthetic (Amide)
|
Steril-Gene Life Sciences (P) Ltd.
|
India
|
Initial
|
29 December 2021
|
29 December 2026
|
| View |
|
DR-XY44315
|
Pemetrexed (as disodium hemipentahydrate)
|
Pemirex
|
500 mg
|
Lyophilized Powder for I.V. Infusion
|
Antineoplastic Agent (Folic Acid Analogue)
|
Korea United Pharma Inc.
|
Korea
|
Renewal
|
21 October 2024
|
11 March 2030
|
| View |
|
DRP-10945
|
Ketorolac trometamol
|
Ketorac
|
30mg/mL
|
Solution for Injection (IM/IV)
|
-
|
Gland Pharma Limited
|
India
|
-
|
21 December 2021
|
21 December 2026
|
| View |
|
DR-XY44563
|
Pemetrexed (as disodium hemipentahydrate)
|
Pemirex
|
100 mg
|
Lyophilized Powder for I.V. Infusion
|
Antineoplastic Agent (Folic Acid Analogue)
|
Korea United Pharma Inc.
|
Korea
|
Renewal
|
13 October 2024
|
15 May 2030
|
| View |
|
DRP-10958
|
Ceftriaxone (as Sodium)
|
Goceft
|
1g
|
Powder for Injection (I.V./I.M.)
|
Antibacterial (Third-generation Cephalosporin)
|
Yeluri Formulations Pvt. Ltd.
|
India
|
Initial
|
22 December 2021
|
22 December 2026
|
| View |
|
DR-XY47618
|
Clotrimazole
|
Canesten
|
100 mg
|
Vaginal Tablet
|
-
|
Haupt Pharma Wülfing GmbH
|
Germany
|
-
|
20 December 2021
|
20 December 2026
|
| View |
|
DRP-10976
|
Co-Amoxiclav
|
Clavmari-600
|
600 mg
|
Powder for Injection (IV)
|
-
|
Inject Care Parenterals Pvt. Ltd.
|
India
|
-
|
28 December 2021
|
28 December 2026
|